2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2,3-dimethyl-1,3-oxazolidin-2-yl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone
C25H33N3O2 — CID 159976909
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2,3-dimethyl-1,3-oxazolidin-2-yl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone
2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2,3-dimethyl-1,3-oxazolidin-2-yl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone (PubChem CID 159976909) has the molecular formula C25H33N3O2 and a molecular weight of 407.56 g/mol. Its IUPAC name is 2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2,3-dimethyl-1,3-oxazolidin-2-yl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone.
Molecular Properties
| Compound Name | 2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2,3-dimethyl-1,3-oxazolidin-2-yl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone |
|---|---|
| PubChem CID | 159976909 |
| Molecular Formula | C25H33N3O2 |
| Molecular Weight | 407.56 g/mol |
| Exact Mass | 407.26 |
| IUPAC Name | 2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2,3-dimethyl-1,3-oxazolidin-2-yl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone |
| SMILES | Cc1cnc(C(=O)Cc2ccc(C3(C)OCCN3C)cc2C2=CCC(C)(C)CC2)[nH]1 |
| InChI | InChI=1S/C25H33N3O2/c1-17-16-26-23(27-17)22(29)14-19-6-7-20(25(4)28(5)12-13-30-25)15-21(19)18-8-10-24(2,3)11-9-18/h6-8,15-16H,9-14H2,1-5H3,(H,26,27) |
| InChIKey | YVMIJJZIPDBTGK-UHFFFAOYSA-N |
| XLogP | 4.87 |
| TPSA | 58.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 407.56 |
| LogP ≤ 5 | 4.87 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159976909 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.